Ahmet Varol

Schlieren, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Precision modeling of tumor antigen-specific T-cell responses in humanized mice for preclinical assessment of cancer immunotherapies.

Precision modeling of tumor antigen-specific T-cell responses in humanized mice for preclinical assessment of cancer immunotherapies.

Journal: Journal for immunotherapy of cancer
Published: March 27, 2026

FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors.

FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 23, 2025

Chronic antigen stimulation in melanoma induces T cell exhaustion and limits efficacy of T cell bispecific therapies.

Chronic antigen stimulation in melanoma induces T cell exhaustion and limits efficacy of T cell bispecific therapies.

Journal: Oncoimmunology
Published: September 02, 2025

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.

Journal: Blood
Published: February 20, 2025

The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis.

The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis.

Journal: HemaSphere
Published: January 31, 2024

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Journal: Blood
Published: November 27, 2023

Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine model.

Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine model.

Journal: PloS one
Published: September 30, 2020

Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.

Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.

Journal: The Journal of clinical investigation
Published: April 11, 2019

The role of the NADPH oxidase NOX2 in prion pathogenesis.

The role of the NADPH oxidase NOX2 in prion pathogenesis.

Journal: PLoS pathogens
Published: July 08, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026